Short Communication - (2025) Volume 16, Issue 3
Received: 01-Aug-2025, Manuscript No. hgec-25-174742;
Editor assigned: 04-Aug-2025, Pre QC No. P-174742;
Reviewed: 18-Aug-2025, QC No. Q-174742;
Revised: 22-Aug-2025, Manuscript No. R-174742;
Published:
29-Aug-2025
, DOI: 10.37421/2161-0436.2025.16.297
Citation: Monteiro, Ana Isabel. ”Genetic Recombination: Diversity, Repair, Evolution, Disease.” Human Genet Embryol 16 (2025):297.
Copyright: © 2025 Monteiro I. Ana This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Meiotic recombination is a fundamental process that ensures genetic diversity and proper chromosome segregation. This paper details the initial steps of meiotic recombination, focusing on the formation and repair of programmed DNA double-strand breaks. It highlights how these breaks are precisely regulated in both space and time, involving key protein complexes that orchestrate the entire process, leading to the eventual formation of crossovers between homologous chromosomes[1].
Homologous recombination repair (HRR) is a crucial pathway for maintaining genome stability, especially in repairing DNA double-strand breaks. This research explores the indispensable role of the XPF-ERCC1 complex within HRR. It elaborates on how this endonuclease complex is involved in processing recombination intermediates, emphasizing its significance in ensuring accurate and efficient DNA repair mechanisms[2].
The evolution of genetic recombination rates is a long-standing question in evolutionary biology. This study provides a compelling argument for the role of genetic drift in shaping recombination landscapes. It suggests that while natural selection influences recombination, random fluctuations in allele frequencies can play a significant, perhaps underestimated, role[3].
Meiotic recombination, a cornerstone of sexual reproduction, involves intricate steps from DNA double-strand break formation to exchange of genetic material between homologous chromosomes. This article outlines the complex molecular choreography, highlighting regulatory proteins and pathways that ensure precise and controlled genetic exchange, vital for chromosome segregation and diversity[4].
Genetic recombination doesn't happen uniformly across the genome; instead, it often concentrates in specific regions known as hotspots and is suppressed in coldspots. This paper investigates their distribution and characteristics, shedding light on genetic and epigenetic factors impacting variation and disease susceptibility[5].
The SMC5/6 complex plays a critical, yet not fully understood, role in maintaining genome stability. This research focuses on its involvement in homologous recombination repair, a key pathway for repairing DNA double-strand breaks. The paper elucidates how the SMC5/6 complex participates in various stages of HRR, protecting cellular integrity[6].
Genetic recombination in eukaryotes is a complex and fundamental biological process that generates genetic diversity and ensures proper chromosome segregation during meiosis. This review provides a comprehensive overview of the various mechanisms underlying genetic recombination, discussing their molecular machinery, regulation, and biological significance across different species[7].
Recombination hotspots are genomic regions where genetic crossover events occur at significantly higher frequencies. This paper examines the mechanisms behind these hotspots in mammalian genomes and their profound implications for both evolution and disease. It discusses how factors like DNA sequence motifs and chromatin structure contribute to hotspot formation, influencing population diversity[8].
Meiotic recombination is a tightly regulated process essential for generating genetic diversity and ensuring accurate chromosome segregation. This article delves into the latest molecular mechanisms governing meiotic recombination, highlighting recent advancements in understanding how DNA double-strand breaks are initiated, repaired, and resolved into crossovers, and points towards future research directions[9].
Genetic recombination, while crucial for diversity, can also play a detrimental role in cancer development and progression. This research explores the various mechanisms of genetic recombination in cancer cells, including aberrant homologous recombination, contributing to genomic instability, drug resistance, and tumor evolution, offering insights into potential therapeutic targets[10].
Meiotic recombination is a fundamental process ensuring genetic diversity and proper chromosome segregation [C001]. This intricate choreography, starting from DNA double-strand break formation and culminating in genetic material exchange, is vital for chromosome segregation and diversity, involving specific regulatory proteins and pathways [C004]. Recent advancements delve into the latest molecular mechanisms governing meiotic recombination, focusing on how DNA double-strand breaks are initiated, repaired, and resolved into crossovers, also pointing towards future research directions [C009]. More broadly, genetic recombination in eukaryotes is a complex and fundamental biological process that generates genetic diversity and ensures proper chromosome segregation during meiosis. This process encompasses various homologous and non-homologous recombination pathways, each with distinct molecular machinery, regulation, and biological significance across different species [C007].
Homologous recombination repair (HRR) serves as a crucial pathway for maintaining genome stability, especially in repairing DNA double-strand breaks [C002]. Research highlights the indispensable role of the XPF-ERCC1 complex within HRR, detailing how this endonuclease complex processes recombination intermediates, such as Holliday junctions and D-loops, which is significant for ensuring accurate and efficient DNA repair mechanisms [C002]. Furthermore, the SMC5/6 complex also plays a critical, though not fully understood, role in maintaining genome stability through its involvement in homologous recombination repair. It participates in various stages of HRR, from DNA damage signaling to the resolution of recombination intermediates, underscoring its importance in preventing genomic rearrangements and protecting cellular integrity [C006].
Genetic recombination does not happen uniformly across the genome; instead, it often concentrates in specific regions known as hotspots and is suppressed in coldspots [C005]. Investigations into the distribution and characteristics of these recombination hotspots and coldspots within the human genome shed light on the genetic and epigenetic factors that dictate where recombination events are more likely or less likely to occur, thereby impacting genetic variation and disease susceptibility [C005]. Recombination hotspots are indeed genomic regions where genetic crossover events occur at significantly higher frequencies in mammalian genomes [C008]. Examination of the mechanisms behind these hotspots and their profound implications for both evolution and disease discusses how factors like DNA sequence motifs, chromatin structure, and specific protein binding contribute to hotspot formation, influencing population diversity and predisposition to certain genetic conditions [C008].
The evolution of genetic recombination rates remains a long-standing question in evolutionary biology [C003]. Studies provide a compelling argument for the role of genetic drift in shaping recombination landscapes. They suggest that while natural selection undeniably influences recombination, random fluctuations in allele frequencies, often referred to as genetic drift, can also play a significant, perhaps underestimated, role in the maintenance and evolution of recombination rates across generations [C003].
Despite its essential role in fostering genetic diversity, genetic recombination can paradoxically play a detrimental role in cancer development and progression [C010]. This research explores various mechanisms of genetic recombination in cancer cells, including aberrant homologous recombination and non-homologous end joining pathways. Understanding how these altered recombination processes contribute to genomic instability, drug resistance, and tumor evolution offers crucial insights into potential therapeutic targets for cancer treatment [C010].
Genetic recombination stands as a fundamental biological process vital for generating genetic diversity and ensuring accurate chromosome segregation, particularly during meiosis. The initiation of meiotic recombination involves the precisely regulated formation and repair of programmed DNA double-strand breaks, orchestrated by specific protein complexes that culminate in crossover events between homologous chromosomes. Homologous recombination repair (HRR) pathways are essential for maintaining genome stability, with complexes like XPF-ERCC1 playing an indispensable role in processing recombination intermediates such as Holliday junctions and D-loops, thereby ensuring accurate DNA repair. Similarly, the SMC5/6 complex is critical for HRR, participating in DNA damage signaling and resolving recombination intermediates to prevent genomic rearrangements. Genetic recombination rates are not uniform; they exhibit specific hotspots and coldspots within the genome, influenced by genetic and epigenetic factors that dictate where events are more likely or less likely to occur. These recombination hotspots, particularly in mammalian genomes, hold significant implications for evolution and disease, affecting population diversity and disease susceptibility. The evolution of these recombination landscapes can be profoundly shaped by genetic drift, suggesting a substantial, possibly underestimated, role for random fluctuations in allele frequencies. Across eukaryotes, genetic recombination involves diverse mechanisms, including both homologous and non-homologous pathways, each with unique molecular machinery and regulatory components contributing to biological significance. Paradoxically, while crucial for diversity, genetic recombination can also contribute detrimentally to cancer development by fostering genomic instability, drug resistance, and tumor evolution through aberrant pathways.
None
None
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Human Genetics & Embryology received 309 citations as per Google Scholar report
